University of California San Francisco
Give to UCSF
Keith Yamamoto, PhD, vice chancellor for research at UC San Francisco, has been named to a national advisory group to guide research and clinical decisions about the use of genome editing technologies to treat human disease.
Adult neural stem cells, which are commonly thought of as having the ability to develop into many type of brain cells, are in reality pre-programmed before birth to make very specific types of neurons.
Researchers at UCSF have pulled aside the curtain on a protein informally known as the “wasabi receptor,” revealing at near-atomic resolution structures that could be targeted with anti-inflammatory pain drugs.
UCSF neuroscientist Michael M. Merzenich, PhD, is a winner of the 2015 Fritz J. and Dolores H. Russ Prize, the bioengineering profession’s highest honor.
Bacteria that normally live in and upon us have genetic blueprints that enable them to make thousands of molecules that act like drugs, and some of these molecules might serve as the basis for new human therapeutics, according to UCSF researchers.
Researchers worldwide will now have access to genetic data linked to medical information on a diverse group of more than 78,000 people, enabling investigations into many diseases and conditions.
Scientists at the Gladstone Institutes and UCSF have made an important breakthrough: they have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish.
Scientists at the UCSF-affiliated Gladstone Institutes have devised a new method that allows for the more efficient and complete reprogramming of skin cells into cells that are virtually indistinguishable from heart muscle cells.
The California Institute for Quantitative Biosciences (QB3) will hold a news conference and media tours to launch the institute’s new bioscience incubator, near the UC San Francisco campus at Mission Bay.